Dexamethasone Elixir Recalled for Impurities Above Permissible Levels
Morton Grove Pharmaceuticals is recalling Dexamethasone Elixir USP 0.5 mg/5 mL nationwide due to unknown impurities found at higher than permissible levels in affected lots.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving impurity/degradation specifications. The source text does not report any illnesses, hospitalizations, or injuries; the hazard is chemical/quality-control based and precautionary in nature, making this a moderate-severity recall.
Plain-English summary
Morton Grove Pharmaceuticals, Inc. is recalling Dexamethasone Elixir, USP 0.5 mg/5 mL (8 fl oz / 237 mL bottles) due to failed impurities and degradation specifications. Testing identified unknown impurities in the drug product at levels exceeding what is permissible.
The affected lots are: UV1004, UV1005 (expiration 6/22); UW1014, UW1015 (expiration 1/23); and UW1084 (expiration 7/23). This product is distributed nationwide in the USA and Puerto Rico.
Consumers who have received this medication should contact their healthcare provider or pharmacist for guidance. Patients should not stop taking their medication without medical advice.
The recalled product
- Product
- Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.
- Manufacturer
- Morton Grove Pharmaceuticals, Inc.
- Hazard
- unknown-impurities
- degradation-products
- potency-integrity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #s: UV1004
- UV1005
- Exp 6/22
- UW1014
- UW1015
- Exp 1/23
- UW1084
- Exp 7/23
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27